2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Abe S and Takahashi H A comparative study of the effects of dimethylsulfoxide and glycerol on the bicontinuous cubic structure of hydrated monoolein and its phase behavior. 2007 Chem. Phys. Lipids pmid:17451662
Engblom J Bicontinuous cubic phase: a model for investigating the effects on a lipid bilayer due to a foreign substance. 1996 Chem. Phys. Lipids pmid:9022220
Clogston J et al. Phase behavior of a monoacylglycerol: (myverol 18-99K)/water system. 2000 Chem. Phys. Lipids pmid:11090848
Barauskas J et al. Solubilization of ubiquinone-10 in the lamellar and bicontinuous cubic phases of aqueous monoolein. 1999 Chem. Phys. Lipids pmid:10192931
Barauskas J et al. Towards redox active liquid crystalline phases of lipids: a monoolein/water system with entrapped derivatives of ferrocene. 2003 Chem. Phys. Lipids pmid:12637167
Rosa A et al. Monoolein-based cubosomes affect lipid profile in HeLa cells. 2015 Chem. Phys. Lipids pmid:26341749
Lee SJ et al. Bioadhesive drug delivery system using glyceryl monooleate for the intravesical administration of paclitaxel. 2005 Chemotherapy pmid:16224181
Issa JP et al. Effect of recombinant human bone morphogenetic protein-2 on bone formation in the acute distraction osteogenesis of rat mandibles. 2009 Clin Oral Implants Res pmid:19719732
Nilsson-Ehle P On the specificity of assays for lipases in postheparin plasma. 1984 Clin. Chim. Acta pmid:6488561
Yariv D et al. In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems. 2010 Colloids Surf B Biointerfaces pmid:20363601
Cohen-Avrahami M et al. H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac. 2010 Colloids Surf B Biointerfaces pmid:20189781
Amar-Yuli I and Garti N Transitions induced by solubilized fat into reverse hexagonal mesophases. 2005 Colloids Surf B Biointerfaces pmid:15921902
Imberg A On the microstructures of ethyl acetate/monoolein/water. 2006 Colloids Surf B Biointerfaces pmid:17084597
Garti N et al. Lipolysis and structure controlled drug release from reversed hexagonal mesophase. 2012 Colloids Surf B Biointerfaces pmid:22341515
Hirano S et al. Continuous monitoring of phospholipid vesicle hydrolysis by phospholipase D (PLD) reveals differences in hydrolysis by PLDs from 2 Streptomyces species. 2012 Colloids Surf B Biointerfaces pmid:22391322
Bitan-Cherbakovsky L et al. Structural characterization of lyotropic liquid crystals containing a dendrimer for solubilization and release of gallic acid. 2013 Colloids Surf B Biointerfaces pmid:23973908
Murgia S et al. Cubosome formulations stabilized by a dansyl-conjugated block copolymer for possible nanomedicine applications. 2015 Colloids Surf B Biointerfaces pmid:25829131
Kim JC et al. Monoolein cubic phases containing hydrogen peroxide. 2004 Colloids Surf B Biointerfaces pmid:15276632
Leesajakul W et al. Interaction of cubosomes with plasma components resulting in the destabilization of cubosomes in plasma. 2004 Colloids Surf B Biointerfaces pmid:15261065
Esposito E et al. Monoolein liquid crystalline phases for topical delivery of crocetin. 2018 Colloids Surf B Biointerfaces pmid:30015140
Ericsson EM et al. Glycerol monooleate-blood interactions. 2009 Colloids Surf B Biointerfaces pmid:18996684
Mishraki T et al. Lysozyme entrapped within reverse hexagonal mesophases: physical properties and structural behavior. 2010 Colloids Surf B Biointerfaces pmid:19748240
Komnick H et al. Is monoacylglycerol as an intermediate of triacylglycerol digestion absorbed by Aeshna cyanea larvae? 1996 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:8761172
Bhatt AB et al. Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization. 2015 Curr Drug Deliv pmid:25176029
Maurya L et al. Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization. 2018 Curr Drug Deliv pmid:29629662
Timmers KI et al. Multiple alterations in insulin responses to glucose in islets from 48-h glucose-infused nondiabetic rats. 1990 Diabetes pmid:1977650
Zawalich WS et al. The effect of monooleoylglycerol on insulin secretion from isolated perifused rat islets. 1989 Diabetologia pmid:2668083
Yu X et al. Melanoma therapy with transdermal mitoxantrone cubic phases. 2016 Drug Deliv pmid:25835224
Aboud HM et al. Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting. 2018 Drug Deliv pmid:29869515
Pham AC et al. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging. 2015 Drug Deliv Transl Res pmid:26328930
Peng X et al. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin. 2015 Drug Des Devel Ther pmid:26345516
Costa-Balogh FO et al. Drug release from lipid liquid crystalline phases: relation with phase behavior. 2010 Drug Dev Ind Pharm pmid:19848561
Kwon TK and Kim JC Monoolein cubic phase containing acidic proteinoid: pH-dependent release. 2011 Drug Dev Ind Pharm pmid:20528616
Quiñones OG et al. In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib. 2014 Drug Dev Ind Pharm pmid:23826859
Réeff J et al. New sustained-release intraarticular gel formulations based on monolein for local treatment of arthritic diseases. 2013 Drug Dev Ind Pharm pmid:23078519
Montenegro L et al. In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. 2011 Drug Dev Ind Pharm pmid:21204752
Dai J and Kim JC Photo responsive monoolein cubic phase containing coumarin-Tween 20 conjugates. 2013 Drug Dev Ind Pharm pmid:23902365
Helledi LS and Schubert L Release kinetics of acyclovir from a suspension of acyclovir incorporated in a cubic phase delivery system. 2001 Drug Dev Ind Pharm pmid:11794810
Zhou Y et al. Biological artificial fluid-induced non-lamellar phases in glyceryl monooleate: the kinetics pathway and its digestive process by bile salts. 2014 Drug Dev Ind Pharm pmid:23350691
Ahirrao M and Shrotriya S In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting. 2017 Drug Dev Ind Pharm pmid:28574732
Lee J and Kellaway IW Peptide washout and permeability from glyceryl monooleate buccal delivery systems. 2002 Drug Dev Ind Pharm pmid:12455474
Patil SS et al. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol. 2016 Drug Dev Ind Pharm pmid:26651381
Ganem-Quintanar A et al. Monoolein: a review of the pharmaceutical applications. 2000 Drug Dev Ind Pharm pmid:10900537
Puri V and Bansal AK In vitro-in vivo characterization of release modifying agents for parenteral sustained-release ketorolac formulation. 2004 Drug Dev Ind Pharm pmid:15285335
Okonogi S et al. Development of local injectable dental gel: the influence of certain additives on physicochemical properties of glycerylmonooleate-based formulations. 2004 Drug Dev Ind Pharm pmid:15132177
Rachmawati H et al. Curcumin nanoemulsion for transdermal application: formulation and evaluation. 2015 Drug Dev Ind Pharm pmid:24502271
Shan-Bin G et al. Long-term sustained-released in situ gels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation, in vitro and in vivo evaluation. 2015 Drug Dev Ind Pharm pmid:24502270
Badie H and Abbas H Novel small self-assembled resveratrol-bearing cubosomes and hexosomes: preparation, charachterization, and ex vivo permeation. 2018 Drug Dev Ind Pharm pmid:30095009
Eskinazi-Budge A et al. Preparation of emulsifying wax/glyceryl monooleate nanoparticles and evaluation as a delivery system for repurposing simvastatin in bone regeneration. 2018 Drug Dev Ind Pharm pmid:29847182
Lopes I et al. Toxicity and genotoxicity of organic and inorganic nanoparticles to the bacteria Vibrio fischeri and Salmonella typhimurium. 2012 Ecotoxicology pmid:22314390